Browse the latest research summaries in the field of genetics for spinal cord injury patients and caregivers.
Showing 201-210 of 1,773 results
Cellular and Molecular Neurobiology, 2025 • November 25, 2024
This review comprehensively examines the therapeutic potential of exosomal miRNAs in treating various central nervous system injury diseases. It covers traumatic brain injury, ischemic stroke, intrace...
KEY FINDING: Exo-miR-124 facilitates M2 polarization of microglia through the inhibition of the TLR4 pathway, thereby affecting hippocampal neurogenesis and the recovery of neurological behavior and cognition after TBI.
Journal of Translational Medicine, 2024 • December 3, 2024
This study demonstrated that TET3-mediated demethylation reshapes the methylation patterns of HUCMSCs, enabling their efficient one-step conversion into OPCs and significantly reducing the time requir...
KEY FINDING: TET3 enhances HUCMSC differentiation into OPCs, evidenced by specific marker expression.
eClinicalMedicine, 2024 • December 1, 2024
This meta-analysis used data from the CENTER-TBI and TRACK-TBI studies to explore whether polygenic risk scores (PRS) for PTSD and major depressive disorder (MDD) are associated with the development o...
KEY FINDING: PTSD-PRS was significantly associated with higher adjusted odds of PTSD in both cohorts, with a pooled odds ratio (OR) of 1.55 [95% confidence interval (CI) 1.30–1.84, p < 0.001].
Regenerative Therapy, 2025 • November 20, 2024
Spinal cord ischemia/reperfusion (IR) injury (SCII) can cause major autonomic, sensory, and motor damage and loss. The upregulation of Nrf2, a primary orchestrator of the oxidative stress response, ha...
KEY FINDING: Nrf2 and NFATC2 levels were reduced in PC12 cells after OGD/R treatment.
The Journal of Neuroscience, 2025 • February 19, 2025
This study investigates the effects of disrupting perineuronal nets (PNNs) and diffuse extracellular matrix (dECM) on brain diffusibility using 4-methylumbelliferone (4-MU), an inhibitor of hyaluronan...
KEY FINDING: Oral treatment with 4-methylumbelliferone (4-MU) downregulated PNNs, HA, chondroitin sulfate proteoglycans, and glial fibrillary acidic protein.
Scientific Reports, 2025 • January 8, 2025
This study investigates the role of SIX1 in microglia polarization following spinal cord injury (SCI) in mice. The researchers found that SIX1 expression increases in microglia after SCI and promotes ...
KEY FINDING: SIX1 expression increases in microglia following SCI in mice and is positively correlated with the M1 microglia marker iNOS and negatively correlated with the M2 microglia marker Arg1.
International Medical Case Reports Journal, 2025 • January 4, 2025
This case report describes a 68-year-old male diagnosed with TTR-FAP with an uncommon presentation of spinal cord damage. The patient's symptoms included progressive limb weakness and numbness, autono...
KEY FINDING: The patient presented with a rare manifestation of TTR-FAP, specifically spinal cord damage, which is not commonly associated with the c.148G>A (p.Val50Met) mutation.
Journal of Nanobiotechnology, 2025 • January 1, 2025
This study investigates the effects of Apelin-13, delivered via a ROS-responsive hydrogel, on macrophage polarization and neuroinflammation in a rat model of spinal cord injury (SCI). The hydrogel was...
KEY FINDING: Apelin-13 is significantly downregulated in the injured sites of the SCI model rats since day 14 after modeling.
Scientific Reports, 2025 • January 8, 2025
This study investigates the role of cuproptosis in spinal cord injury (SCI) using bioinformatics analysis of RNA sequencing data from SCI samples. It identifies hub genes, including Cd48 and Mpeg1, an...
KEY FINDING: Two hub genes, Cd48 and Mpeg1, were identified and exhibited a strong positive correlation (R = 0.92) and shared similar pathways, suggesting their importance in SCI.
Scientific Reports, 2025 • January 14, 2025
This study investigates the therapeutic effect of NaHS on neuropathic pain using the spared nerve injury (SNI) model in mice, focusing on astrocytes and glutamate. The findings reveal that NaHS enhanc...
KEY FINDING: SNI induces chronic pain and depressive-like behaviors in mice, evidenced by decreased mechanical pain threshold, thermal pain latency, and reduced exploratory behavior.